Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer

Journal of Immunological Methods

Volumn 400-401, Issue 1, 2013, Pages 58-69

  Ostendorff, Heather P ^a   Awad, Amany ^a   Braunschweiger, Karen I ^a   Liu, Ziying ^a   Wan, Zhi ^a   Rothschild, Kenneth J ^a,b   Lim, Mark J ^a  

^a AMBERGEN INC   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Autoantibodies; Biomarker; Colorectal cancer; Multiplex immunoassay; Tumor associated antigens

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER DIAGNOSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; MASS SCREENING; MORTALITY; OCCULT BLOOD; PERSONALIZED MEDICINE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; RETICULOCYTE LYSATE; SEROLOGY;

EID: 84888435500     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.09.013     Document Type: Article

References (50)

1. Ahlquist D.A. Fecal occult blood testing for colorectal cancer. Can we afford to do this?. Gastroenterol. Clin. North Am. 1997, 26:41.
2. Anderson K.S., LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J. Proteome Res. 2005, 4:1123.
3. Anderson K.S., Sibani S., Wallstrom G., Qiu J., Mendoza E.A., Raphael J., Hainsworth E., Montor W.R., Wong J., Park J.G., Lokko N., Logvinenko T., Ramachandran N., Godwin A.K., Marks J., Engstrom P., Labaer J. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J. Proteome Res. 2011, 10:85.
4. Babel I., Barderas R., Diaz-Uriarte R., Martinez-Torrecuadrada J.L., Sanchez-Carbayo M., Casal J.I. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol. Cell. Proteomics 2009, 8:2382.
5. Belousov P.V., Kuprash D.V., Sazykin A.Y., Khlgatian S.V., Penkov D.N., Shebzukhov Y.V., Nedospasov S.A. Cancer-associated antigens and antigen arrays in serological diagnostics of malignant tumors. Biochemistry (Mosc) 2008, 73:562.
6. Bentley D.R., Balasubramanian S., Swerdlow H.P., Smith G.P., Milton J., Brown C.G., Hall K.P., Evers D.J., Barnes C.L., Bignell H.R., Boutell J.M., Bryant J., Carter R.J., Keira Cheetham R., Cox A.J., Ellis D.J., Flatbush M.R., Gormley N.A., Humphray S.J., Irving L.J., Karbelashvili M.S., Kirk S.M., Li H., Liu X., Maisinger K.S., Murray L.J., Obradovic B., Ost T., Parkinson M.L., Pratt M.R., Rasolonjatovo I.M., Reed M.T., Rigatti R., Rodighiero C., Ross M.T., Sabot A., Sankar S.V., Scally A., Schroth G.P., Smith M.E., Smith V.P., Spiridou A., Torrance P.E., Tzonev S.S., Vermaas E.H., Walter K., Wu X., Zhang L., Alam M.D., Anastasi C., Aniebo I.C., Bailey D.M., Bancarz I.R., Banerjee S., Barbour S.G., Baybayan P.A., Benoit V.A., Benson K.F., Bevis C., Black P.J., Boodhun A., Brennan J.S., Bridgham J.A., Brown R.C., Brown A.A., Buermann D.H., Bundu A.A., Burrows J.C., Carter N.P., Castillo N., Chiara E.C.M., Chang S., Neil Cooley R., Crake N.R., Dada O.O., Diakoumakos K.D., Dominguez-Fernandez B., Earnshaw D.J., Egbujor U.C., Elmore D.W., Etchin S.S., Ewan M.R., Fedurco M., Fraser L.J., Fuentes Fajardo K.V., Scott Furey W., George D., Gietzen K.J., Goddard C.P., Golda G.S., Granieri P.A., Green D.E., Gustafson D.L., Hansen N.F., Harnish K., Haudenschild C.D., Heyer N.I., Hims M.M., Ho J.T., Horgan A.M., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008, 456:53.
7. Berger B.M., Schroy P.C., Rosenberg J.L., Lai-Goldman M., Eisenberg M., Brown T., Rochelle R.B., Billings P.R. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin. Colorectal Cancer 2006, 5:338.
8. Brown D.A., Hance K.W., Rogers C.J., Sansbury L.B., Albert P.S., Murphy G., Laiyemo A.O., Wang Z., Cross A.J., Schatzkin A., Danta M., Srasuebkul P., Amin J., Law M., Breit S.N., Lanza E. Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?. Cancer Epidemiol. Biomarkers Prev. 2012, 21:337.
9. Casiano C.A., Mediavilla-Varela M., Tan E.M. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol. Cell. Proteomics 2006, 5:1745.
10. Chapman C.J., Murray A., McElveen J.E., Sahin U., Luxemburger U., Tureci O., Wiewrodt R., Barnes A.C., Robertson J.F. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008, 63:228.
11. Chee M., Yang R., Hubbell E., Berno A., Huang X.C., Stern D., Winkler J., Lockhart D.J., Morris M.S., Fodor S.P. Accessing genetic information with high-density DNA arrays. Science 1996, 274:610.
12. Chen Y., Lin P., Qiu S., Peng X.X., Looi K., Farquhar M.G., Zhang J.Y. Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. Int. J. Oncol. 2007, 30:1137.
13. Creeden J., Junker F., Vogel-Ziebolz S., Rex D. Serum tests for colorectal cancer screening. Mol. Diagn. Ther. 2011, 15:129.
14. Davies R.J., Miller R., Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat. Rev. Cancer 2005, 5:199.
15. de Voer R.M., van der Klis F.R., Engels C.W., Rijkers G.T., Sanders E.A., Berbers G.A. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin. Vaccine Immunol. 2008, 15:1188.
16. Dettloff R., Yang E., Rulison A., Chow A., Farinas J. Nucleic acid amplification of individual molecules in a microfluidic device. Anal. Chem. 2008, 80:4208.
17. Doolittle B.R., Emanuel J., Tuttle C., Costa J. Detection of the mutated K-Ras biomarker in colorectal carcinoma. Exp. Mol. Pathol. 2001, 70:289.
18. Fodor S.P., Read J.L., Pirrung M.C., Stryer L., Lu A.T., Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 1991, 251:767.
19. Fouda G.G., Leke R.F., Long C., Druilhe P., Zhou A., Taylor D.W., Johnson A.H. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clin. Vaccine Immunol. 2006, 13:1307.
20. Fulton R.J., McDade R.L., Smith P.L., Kienker L.J., Kettman J.R. Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 1997, 43:1749.
21. Gunderson K.L., Kruglyak S., Graige M.S., Garcia F., Kermani B.G., Zhao C., Che D., Dickinson T., Wickham E., Bierle J., Doucet D., Milewski M., Yang R., Siegmund C., Haas J., Zhou L., Oliphant A., Fan J.B., Barnard S., Chee M.S. Decoding randomly ordered DNA arrays. Genome Res. 2004, 14:870.
22. Hellemons M.E., Mazagova M., Gansevoort R.T., Henning R.H., de Zeeuw D., Bakker S.J., Lambers-Heerspink H.J., Deelman L.E. Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes. Diabetes Care 2012, 35:2340.
23. Howlader N., Noone A.M., Krapcho M., Neyman N., Aminou R., Waldron W., Altekruse S.F., Kosary C.L., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Eisner M.P., Lewis D.R., Chen H.S., Feuer E.J., Cronin K.A. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) 2012, National Cancer Institute, Bethesda, MD.
24. Hudson M.E., Pozdnyakova I., Haines K., Mor G., Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17494.
25. Keefe A.D., Wilson D.S., Seelig B., Szostak J.W. One-step purification of recombinant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag. Protein Expr. Purif. 2001, 23:440.
26. Koziol J.A., Zhang J.Y., Casiano C.A., Peng X.X., Shi F.D., Feng A.C., Chan E.K., Tan E.M. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin. Cancer Res. 2003, 9:5120.
27. Lin C.H., Yeakley J.M., McDaniel T.K., Shen R. Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol. Biol. 2009, 496:129.
28. Liu W., Wang P., Li Z., Xu W., Dai L., Wang K., Zhang J. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Scand. J. Immunol. 2009, 69:57.
29. Marchio C., Dowsett M., Reis-Filho J.S. Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box. BMC Med. 2011, 9:41.
30. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L., Jarvie T.P., Jirage K.B., Kim J.B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., Rothberg J.M. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376.
31. Nozoe T., Yasuda M., Honda M., Inutsuka S., Korenaga D. Clinicopathologic significance in serum presence of anti-p53 antibody in patients with colorectal carcinoma. Hepatogastroenterology 2007, 54:1422.
32. Opalka D., Lachman C.E., MacMullen S.A., Jansen K.U., Smith J.F., Chirmule N., Esser M.T. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin. Diagn. Lab. Immunol. 2003, 10:108.
33. Plant A.L., Locascio-Brown L., Haller W., Durst R.A. Immobilization of binding proteins on nonporous supports. Comparison of protein loading, activity, and stability. Appl. Biochem. Biotechnol. 1991, 30:83.
34. Reuschenbach M., von Knebel Doeberitz M., Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol. Immunother. 2009, 58:1535.
35. Rex D.K., Johnson D.A., Anderson J.C., Schoenfeld P.S., Burke C.A., Inadomi J.M. American college of gastroenterology guidelines for colorectal cancer screening 2008. Am. J. Gastroenterol. 2009, 104:739.
36. Saleh J., Kreissler-Haag D., Montenarh M. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53. Int. J. Oncol. 2004, 25:1149.
37. Schlottmann S.A., Jain N., Chirmule N., Esser M.T. A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J. Immunol. Methods 2006, 309:75.
38. Storr S.J., Chakrabarti J., Barnes A., Murray A., Chapman C.J., Robertson J.F. Use of autoantibodies in breast cancer screening and diagnosis. Expert. Rev. Anticancer. Ther. 2006, 6:1215.
39. Su B.B., Shi H., Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J. Gastroenterol. 2012, 18:2121.
40. Subramanian S., Klosterman M., Amonkar M.M., Hunt T.L. Adherence with colorectal cancer screening guidelines: a review. Prev. Med. 2004, 38:536.
41. Toth K., Sipos F., Kalmar A., Patai A.V., Wichmann B., Stoehr R., Golcher H., Schellerer V., Tulassay Z., Molnar B. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PloS One 2012, 7:e46000.
42. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530.
43. Vijan S., Inadomi J., Hayward R.A., Hofer T.P., Fendrick A.M. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment. Pharmacol. Ther. 2004, 20:507.
44. Walhout A.J., Temple G.F., Brasch M.A., Hartley J.L., Lorson M.A., van den Heuvel S., Vidal M. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol. 2000, 328:575.
45. Wallin U., Glimelius B., Jirstrom K., Darmanis S., Nong R.Y., Ponten F., Johansson C., Pahlman L., Birgisson H. Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br. J. Cancer 2011, 104:1619.
46. Waterboer T., Sehr P., Pawlita M. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 2006, 309:200.
47. Wollert K.C., Kempf T. Growth differentiation factor 15 in heart failure: an update. Curr. Heart Fail. Rep. 2012, 9:337.
48. Woolf S.H. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer. N. Engl. J. Med. 2004, 351:2755.
49. Xue H., Lu B., Zhang J., Wu M., Huang Q., Wu Q., Sheng H., Wu D., Hu J., Lai M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 2010, 9:545.
50. Zhang J.Y., Casiano C.A., Peng X.X., Koziol J.A., Chan E.K., Tan E.M. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol. Biomarkers Prev. 2003, 12:136.